Literature DB >> 15596729

Per-Arnt-Sim domain-dependent association of cAMP-phosphodiesterase 8A1 with IkappaB proteins.

Ping Wu1, Peng Wang.   

Abstract

Phosphodiesterase (PDE) 8A1 is a cAMP-specific PDE isozyme characterized by the presence of a Per-Arnt-Sim (PAS) domain. However, the function(s) of the PAS domain has remained unknown. In this study, using a lysate of HEK293 cells overexpressing recombinant human PDE8A1, we detected a physical association between PDE8A1 and endogenous IkappaBbeta by an antibody array technique. The association was specific for PDE8A1 and depended on the presence of the PAS domain. Subsequent coimmunoprecipitation experiments revealed that, in addition to IkappaBbeta, other IkappaB family members examined (p105, p100, and IkappaBalpha) also associated with PDE8A1. Furthermore, it was found that PDE8A1 competed with the p65/p50 NF-kappaB for IkappaBbeta binding. Taken together, these data indicate that PDE8A1, through its PAS domain, may bind with IkappaB proteins in a region containing their ankyrin repeats. Functionally, in vitro and in vivo experiments demonstrated that the association with IkappaB greatly enhanced the enzyme activity of PDE8A1. However, the PDE8A1-IkappaB association did not affect NF-kappaB activation. The biological role of the PDE8A1-IkappaB association remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596729      PMCID: PMC539753          DOI: 10.1073/pnas.0407649101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Molecular mechanisms for protein kinase A-mediated modulation of immune function.

Authors:  Knut Martin Torgersen; Torkel Vang; Hilde Abrahamsen; Sheraz Yaqub; Kjetil Taskén
Journal:  Cell Signal       Date:  2002-01       Impact factor: 4.315

2.  KappaB-Ras binds to the unique insert within the ankyrin repeat domain of IkappaBbeta and regulates cytoplasmic retention of IkappaBbeta x NF-kappaB complexes.

Authors:  Yi Chen; Joann Wu; Gourisankar Ghosh
Journal:  J Biol Chem       Date:  2003-04-02       Impact factor: 5.157

3.  Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans.

Authors:  Michiko Gamanuma; Keizo Yuasa; Takashi Sasaki; Naoki Sakurai; Jun Kotera; Kenji Omori
Journal:  Cell Signal       Date:  2003-06       Impact factor: 4.315

4.  Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution.

Authors:  P Wang; P Wu; R W Egan; M M Billah
Journal:  Gene       Date:  2001-12-12       Impact factor: 3.688

Review 5.  The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Authors:  D M Rothwarf; M Karin
Journal:  Sci STKE       Date:  1999-10-26

6.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.

Authors:  F Mercurio; J A DiDonato; C Rosette; M Karin
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

Review 7.  Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

Authors:  Marco Conti; Wito Richter; Celine Mehats; Gabriel Livera; Jy-Young Park; Catherine Jin
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

Review 8.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

9.  An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.

Authors:  Junan Li; Sang Hoon Joo; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

10.  Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.

Authors:  Peng Wang; Ping Wu; Robert W Egan; M Motasim Billah
Journal:  Gene       Date:  2003-09-18       Impact factor: 3.688

View more
  12 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Role of intracellular domains in the function of the herg potassium channel.

Authors:  Moza Al-Owais; Kate Bracey; Dennis Wray
Journal:  Eur Biophys J       Date:  2009-01-27       Impact factor: 1.733

Review 4.  Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.

Authors:  Liliane Tetsi; Anne-Laure Charles; Stéphanie Paradis; Anne Lejay; Samy Talha; Bernard Geny; Claire Lugnier
Journal:  Cell Mol Life Sci       Date:  2016-12-30       Impact factor: 9.261

5.  Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Authors:  Zier Yan; Huanchen Wang; Jiwen Cai; Hengming Ke
Journal:  Protein Expr Purif       Date:  2008-10-19       Impact factor: 1.650

Review 6.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

7.  Phosphodiesterase-8A binds to and regulates Raf-1 kinase.

Authors:  Kim M Brown; Jon P Day; Elaine Huston; Bastian Zimmermann; Kornelia Hampel; Frank Christian; David Romano; Selim Terhzaz; Louisa C Y Lee; Miranda J Willis; David B Morton; Joseph A Beavo; Masami Shimizu-Albergine; Shireen A Davies; Walter Kolch; Miles D Houslay; George S Baillie
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 8.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

9.  Mitochondrial sub-cellular localization of cAMP-specific phosphodiesterase 8A in ovarian follicular cells.

Authors:  Amel Lounas; Nathalie Vernoux; Marc Germain; Marie-Eve Tremblay; François J Richard
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

10.  Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.

Authors:  Huanchen Wang; Zier Yan; Serena Yang; Jiwen Cai; Howard Robinson; Hengming Ke
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.